Skip to main content
SpringerLink
Log in

Trimetazidine: a well tolerated and novel alternative in stable angina pectoris

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Task Force of the European Society of Cardiology. Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997 Mar; 18: 394–413

    Article  Google Scholar 

  2. British National Formulary. No. 39. London: The Pharmaceutical Press, 2000 Mar

  3. McClellan KJ, Plosker GL. Trimetazidine: a review of its use in stable angina pectoris and other coronary conditions. Drugs 1999; 58(1): 143–57

    Article  PubMed  CAS  Google Scholar 

  4. AHFS Drug Information. Bethesda: American Society of Health-System Pharmacists, 2000: 1559-65, 1580-7, 1731-3

  5. Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina: comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994 Mar; 37: 279–88

    Article  PubMed  CAS  Google Scholar 

  6. Passeron J. Efficacité de la trimétazidine dans l’angor d’effort stable de l’innsuffisant coronarien chronique. Étude à double insu contre placebo. Presse Med 1986 Oct 16; 15: 1775–8

    PubMed  CAS  Google Scholar 

  7. Gallet M. Efficacité clinique de la trimétazidine dans l’angor d’effort stable. Étude contrôlée à double insu contre placebo. Presse Med 1986 Oct 16; 15: 1779–82

    PubMed  CAS  Google Scholar 

  8. Dalla-Volta S, Maraglino G, Delia-Valentina, P et al. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther 1990 Aug; 4 Suppl. 4: 853–9

    Article  PubMed  Google Scholar 

  9. Szwed H, Pachocki R, Domzal-Bochenska M, et al. Efficacy and tolerance of trimetazidine in combination with a conventional antianginal drug in patients with stable effort angina. Diagn Treat Cardiol 1997; 4: 237–47

    Google Scholar 

  10. Szwed H, Sadowski Z, Pachocki R, et al. Anti-ischaemic effects and tolerability of trimetazidine in coronary diabetic patients: a sub-study from TRIMPOL-1. Cardiovasc Drugs Ther 1999; 13(3): 217–22

    Article  PubMed  CAS  Google Scholar 

  11. Michaelides AP, Spiropoulos K, Dimopoulos K. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Invest 1997 Jan; 13: 8–14

    Article  CAS  Google Scholar 

  12. Lu C, Dabrowski P, Fragasso G, et al. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol 1998; 82: 898–901

    Article  PubMed  CAS  Google Scholar 

  13. Shlyakhto EV, Vakhrameyeva IV, Nifontoff EM, et al. Chronic effects of myocardial cytoprotector trimetazidine for CAD: clinical, biochemical and echocardiographical follow-up. Eur Heart J 1998; 19 Abstract Suppl.: 191

    Google Scholar 

  14. Levy S, Group of South of France investigators. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Am J Cardiol 1995 Aug 24; 76: 12B–6B

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trimetazidine: a well tolerated and novel alternative in stable angina pectoris. Drugs Ther. Perspect 16, 1–5 (2000). https://doi.org/10.2165/00042310-200016030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200016030-00001

Keywords

Search

Navigation